Prostate cancer in 432 men aged < 50  years in the prostate‐specific antigen era: a new outlook

ConclusionsThe clinical presentation and prognosis of young patients has changed dramatically during the PSA era. Patients nowadays present with lower ‐risk disease that can be treated adequately, with reassuring biochemical recurrence rates at 5 years post‐surgery. AS appears to be safe in patients with low‐risk. PCa.

Source: BJU International - October 10, 2018 Category: Urology & Nephrology Authors: Ilan Gielchinsky, John Chang, Thomas Cusick, Warick Delprado, Quoc Nguyen, Carlo Yuen, Richard Savdie, Maret B öhm, Anne‐Maree Haynes, Matthijs J. Scheltema, Phillip D. Stricker Tags: Original Article Source Type: research